Jorge Gómez-Miragaya

7PUBLICATIONS
54CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Nov 19, 2025
Activated glucocorticoid receptor is an estrogen receptor silencer in ER+ metastatic breast cancer.

Madhuri Manivannan, Charly Jehanno, Michal Kloc

|May 30, 2025
RANK Pathway Inhibition Sensitizes Triple-Negative Breast Cancer to CDK4/6 Inhibitors and Enhances Immune Response.

Inês Gomes, Maria Martelo, Rúben D Vilela

|Jun 01, 2023
Nicotinamide N-methyltransferase sustains a core epigenetic program that promotes metastatic colonization in breast cancer.

Joana Pinto Couto, Milica Vulin, Charly Jehanno

|Mar 07, 2023
RANK is a poor prognosis marker and a therapeutic target in ER-negative postmenopausal breast cancer.

Marina Ciscar, Eva M Trinidad, Gema Perez-Chacon

|Aug 15, 2019
Epigenetic inactivation of the splicing RNA-binding protein CELF2 in human breast cancer.

Laia Piqué, Alexia Martinez de Paz, David Piñeyro

|Jul 20, 2019
The Altered Transcriptome and DNA Methylation Profiles of Docetaxel Resistance in Breast Cancer PDX Models.

Jorge Gómez-Miragaya, Sebastián Morán, Maria Eréndira Calleja-Cervantes

Pageof 2

Frequent Collaborators

3 joint publications

Eva M Trinidad

2 joint publications

Charly Jehanno

2 joint publications

Marie-May Coissieux

2 joint publications

Alexander Schmidt